학술논문
Human immunodeficiency virus type 1 genotypic and pharmacokinetic determinants of the virological response to lopinavir-ritonavir-containing therapy in protease inhibitor-experienced patients
Document Type
Article
Author
Masquelier, B.; Breilh, D.; Neau, D.; Lawson-Ayayi, S.; Lavignolle, V.; Ragnaud, J.-M.; Dupon, M.; Morlat, P.; Dabis, F.; Fleury, H.; Beylot, J.; Le Bras, M.; Pellegrin, J.L.; Salamon, R.; Chêne, G.; Bernard, N.; Lacoste, D.; Malvy, D.; Moreau, J.-F.; Mercié, P.; Commenges, D.; Jacqmin-Gadda, H.; Thiébaut, R.; Blaizeau, M.J.; Decoin, M.; Formaggio, A.M.; Delveaux, S.; Labarerre, S.; Uwamaliya, B.; Vimard, E.; Merchadou, L.; Palmer, G.; Touchard, D.; Dutoit, D.; Pereira, F.; Boulant, B.; Couzigou, P.; Bonarek, M.; Bonnet, F.; Coadou, B.; Gelie, P.; Jaubert, D.; Nouts, C.; Pellegrin, I.; Dutronc, H.; Cipriano, G.; Lafarie, S.; Lacut, J.Y.; Viallard, J.F.; Faure, I.; Rispal, P.; Cipriano, C.; Leng, B.; Djossou, F.; Pivetaud, J.P.; Taupin, J.L.; De La Taille, C.; Galperine, T.; Ochoa, A.; Chambon, D.
Source
In: Antimicrobial Agents and Chemotherapy . (Antimicrobial Agents and Chemotherapy, September 2002, 46(9):2926-2932)
Subject
Language
English
ISSN
00664804